Ferumoxytol for treatment of iron deficiency anemia in patients with chronic kidney disease.

@article{Coyne2009FerumoxytolFT,
  title={Ferumoxytol for treatment of iron deficiency anemia in patients with chronic kidney disease.},
  author={Daniel W. Coyne},
  journal={Expert opinion on pharmacotherapy},
  year={2009},
  volume={10 15},
  pages={2563-8}
}
BACKGROUND Iron deficiency anemia (IDA) is a common problem in patients with chronic kidney disease (CKD). Use of intravenous (i.v.) iron effectively treats the resultant anemia, but available iron products have side effects or dosing regimens that limit safety and convenience. OBJECTIVE Ferumoxytol (Feraheme) is a new i.v. iron product recently approved for use in treatment of IDA in CKD patients. This article reviews the structure, pharmacokinetics, and clinical trial results on ferumoxytol… CONTINUE READING
Highly Cited
This paper has 128 citations. REVIEW CITATIONS

Topics

Statistics

0204060201020112012201320142015201620172018
Citations per Year

129 Citations

Semantic Scholar estimates that this publication has 129 citations based on the available data.

See our FAQ for additional information.